ProfileGDS4459 / ENSG00000171916
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 65% 41% 40% 75% 43% 38% 45% 33% 40% 25% 40% 43% 13% 59% 14% 8% 69% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.9865
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.1141
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.9540
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 45.4975
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.1243
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.9538
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.2345
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.6833
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.9540
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.3625
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.9540
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.0943
GSM623476group B, liver allograft wedge biopsie placebo treatment 32.6213
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.7159
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.5814
GSM623479group B, liver allograft wedge biopsie placebo treatment 62.818
GSM623480group B, liver allograft wedge biopsie placebo treatment 75.1869